Ischemic Preconditioning Clinical Trial
Official title:
The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response
The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans
Remote ischemic preconditioning (RIPC) results in a powerful and widespread protective effect against subsequent prolonged ischemia-reperfusion (IR) injury of distant organs and systemic inflammatory responses, both of which are key elements in the evolution of local and multiorgan effects of many clinical IR syndromes. The signal transduction within the target organ to generate ischemia tolerance, and the effects of RIPC on systemic anti-inflammatory pathways, however, remain to be elucidated fully. Particularly, data regarding the mechanisms of 'second window' protection (a resurgence of protection 24-72 hrs after the initial RIPC stimulus) is scant; even less is known of the effects of repeated RIPC, and a potential 'third window' of protection. Our preliminary data and several recent publications have shown that the biology of RIPC and exercise show considerable overlap. This research has raised the possibility of a reciprocal effect between RIPC and exercise, with chronic exercise being a model of the potential effects of 'chronic preconditioning'. This is relevant, as repeated RIPC might be a strategy to improve exercise function in those with limited exercise tolerance e.g. heart failure. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01235286 -
Cutaneous Remote Ischemic Preconditioning in Plastic Surgery
|
N/A | |
Completed |
NCT01118000 -
Study on the Cardioprotection and Humoral Mechanism of Limb Ischemia Preconditioning
|
N/A | |
Completed |
NCT00184912 -
The Effect of Caffeine on Ischemic Preconditioning
|
N/A | |
Recruiting |
NCT03380663 -
Conditioning Based Intervention Strategies
|
N/A | |
Completed |
NCT03023150 -
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
|
N/A | |
Completed |
NCT02981680 -
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT00821522 -
The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery
|
Phase 1 | |
Not yet recruiting |
NCT05957523 -
Effects of Remote Ischemic Preconditioning on Components of Peripheral Blood and Gut Microbiome (EMINENT)
|
N/A | |
Completed |
NCT04887610 -
Factors That Influence Blood Vessel Regulation During Exercise in Humans
|
N/A | |
Completed |
NCT05219344 -
Tissue Flossing and Lower Limb Neuromuscular Function
|
N/A | |
Completed |
NCT00453531 -
Model System for Transient Forearm Blood Vessel Dysfunction
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412888 -
Effect of CoQ10 on the Endocrine Function of Skeletal Muscle
|
N/A | |
Recruiting |
NCT03900390 -
The Study of Potency of Cross-preconditioning to Prevent Ischemic-reperfusion Injury for Heart Transplantation Recipient
|
N/A | |
Completed |
NCT02411266 -
Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage
|
N/A | |
Completed |
NCT02666235 -
Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR)
|
Phase 2 | |
Terminated |
NCT01743937 -
A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
|
Phase 4 | |
Completed |
NCT04016857 -
Remote Ischemic Preconditioning During Lower Limb Revascularization
|
N/A | |
Not yet recruiting |
NCT05653505 -
Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis
|
||
Completed |
NCT02965547 -
Remote Ischemic Preconditioning of Dynamic Cerebral Autoregulation in Healthy Adults
|
N/A | |
Completed |
NCT05350683 -
Effect of Remote Ischemic Preconditioning on the Incidence of Contrast Induced Nephropathy in Patients Undergoing EVAR
|
Phase 2 |